Life insurance with lupus, MS or rheumatoid arthritis

Lupus, multiple sclerosis (MS) and rheumatoid arthritis (RA) can all be insured, but they are underwritten case by case because each ranges from mild to disabling. Insurers generally look at how active the disease is, whether it has affected major organs, how long you have been stable, which medicines you take and whether you can work. Mild, stable disease with long remission or slow progression is typically viewed far more favorably than severe, fast-changing disease.

What these conditions have in common

All three are autoimmune or immune-mediated conditions, in which the immune system attacks the body's own tissue. They tend to come in flares and quiet periods, and modern treatments have changed outcomes for many people. Because their course varies so much, underwriting focuses less on the label and more on the specifics of your case.

The Centers for Disease Control and Prevention estimates that about 204,000 people in the U.S. have systemic lupus erythematosus (page updated May 15, 2024); 9 in 10 are women, and Black individuals with lupus have higher death rates and die at earlier ages. That pattern is one reason lupus underwriting is sensitive to severity and organ involvement.

Lupus

Systemic lupus (SLE) can involve skin, joints, kidneys, heart, lungs and the nervous system. Underwriters typically ask:

• Which organs are involved? Kidney involvement (lupus nephritis) is a major factor; see life insurance with kidney disease. Heart, lung or brain involvement also weighs heavily.
• Is it systemic or limited to the skin? Discoid (skin-only) lupus is generally viewed differently from systemic disease.
• Disease activity and flares. Frequency of flares, hospitalizations and the date of the last significant one.
• Medications. Hydroxychloroquine, steroids, immunosuppressants or biologics signal different severity levels.
• Time since diagnosis and stability. Several years of low disease activity helps.

Multiple sclerosis

MS affects the central nervous system. Typical questions:

• Type of MS. Relapsing-remitting, progressive or a first episode are underwritten differently.
• Relapses. Number and recency of relapses, and whether recovery was complete.
• Disability level. Needing a cane or wheelchair, difficulty walking, or cognitive changes are important markers. Insurers may ask for a neurologist's disability rating.
• MRI findings and treatment. Disease-modifying therapies, and the stability of scans.
• Time since diagnosis. A long, stable course is a favorable sign.

Rheumatoid arthritis

RA mostly affects joints but can involve the lungs, heart and eyes. Typical questions:

• Severity and joint damage. Erosions seen on X-rays, joint replacements and functional limits.
• Medications. Methotrexate, biologics, JAK inhibitors or long-term steroids indicate how active the disease has been.
• Remission. Documented low disease activity or remission on treatment is favorable.
• Extra-joint disease. Lung scarring or vasculitis changes the picture.
• Ability to work and daily activities.

CDC groups several conditions, including RA, gout, lupus and fibromyalgia, under the broad heading of arthritis, which its 2019 National Health Interview Survey QuickStats showed was more common in women (24.3% versus 18.3% of men) and rose steadily with age. Underwriters distinguish between degenerative osteoarthritis, which is common and usually minor for life insurance, and inflammatory RA, which is treated with powerful immune-modifying drugs and is evaluated more cautiously.

How outcomes typically range

Insurers differ widely, so treat the following as general patterns, not rules:

• Mild, stable, treated disease with no organ involvement may be offered coverage at standard or modestly rated classes by some companies.
• Moderate disease with ongoing flares, or major medication use, is more likely to receive a table rating.
• Severe or rapidly progressing disease, significant disability or major organ involvement is often postponed or declined for individually underwritten policies.

See life insurance rate classes: preferred plus to substandard and table ratings and flat extras explained for how ratings work.

What the insurer will see

Applications ask about diagnosis dates, treatments and disability. Insurers check prescription histories (see how insurers check your prescription history), and for larger amounts or unclear files they request an attending physician statement from your rheumatologist or neurologist. The treatment you receive signals the condition even if you do not mention it, so omissions rarely go unnoticed, and a misstatement can lead to a contested claim (see the two-year contestability period).

Steps before you apply

1. Get a specialist summary. Ask your rheumatologist or neurologist for a letter covering diagnosis date, type, current activity, organ involvement, medications and functional status.
2. List your medicines with start dates. Changes in drugs matter to underwriters.
3. Note relapses or flares and hospitalizations over the past several years.
4. Apply when stable. A period of quiet disease helps, but do not delay coverage you need indefinitely; a new relapse can make the file harder.
5. Compare insurers, ideally through an independent agent, since the same file can be priced differently.
6. Consider disability planning too. Conditions that can affect work may make disability coverage as important as life coverage, although it is also underwritten (see life insurance vs disability insurance: which to buy first). A waiver of premium rider, which pays premiums if you become disabled, is worth asking about when you buy.
7. Review group options. Employer coverage is typically available without individual medical review up to a limit.

A hypothetical example

Say a 41-year-old has rheumatoid arthritis diagnosed 8 years ago, in remission on one medication for 3 years, with no joint replacements and a full-time job. Some insurers could view that favorably and offer a mild rating or better. Say a 41-year-old with lupus nephritis, frequent flares and recent hospitalization applies. That application would more likely be postponed or declined. These cases are illustrative only.

Key takeaways

• Lupus, MS and RA are underwritten by severity, activity, organ involvement, medications and function, not just by name.
• Mild, stable, well-treated disease is much more insurable than severe or fast-progressing disease.
• A specialist's letter and a clear treatment history make applications smoother.
• Compare several insurers, and consider disability coverage alongside life insurance.